| An expanded evaluation of protein function prediction methods shows an improvement in accuracy Y Jiang, TR Oron, WT Clark, AR Bankapur, D D’Andrea, R Lepore, ... Genome biology 17 (1), 1-19, 2016 | 414 | 2016 |
| The CAFA challenge reports improved protein function prediction and new functional annotations for hundreds of genes through experimental screens N Zhou, Y Jiang, TR Bergquist, AJ Lee, BZ Kacsoh, AW Crocker, ... bioRxiv, 653105, 2019 | 359 | 2019 |
| DisProt 7.0: a major update of the database of disordered proteins D Piovesan, F Tabaro, I Mičetić, M Necci, F Quaglia, CJ Oldfield, ... Nucleic acids research 45 (D1), D219-D227, 2017 | 332 | 2017 |
| DisProt: intrinsic protein disorder annotation in 2020 A Hatos, B Hajdu-Soltész, AM Monzon, N Palopoli, L Álvarez, ... Nucleic acids research 48 (D1), D269-D276, 2020 | 243 | 2020 |
| Characterization of conserved properties of hemagglutinin of H5N1 and human influenza viruses: possible consequences for therapy and infection control V Veljkovic, N Veljkovic, CP Muller, S Müller, S Glisic, V Perovic, H Köhler BMC Structural Biology 9 (1), 21, 2009 | 98 | 2009 |
| Application of the EIIP/ISM bioinformatics concept in development of new drugs V Veljkovic, N Veljkovic, JA Este, A Huther, U Dietrich Current medicinal chemistry 14 (4), 441-453, 2007 | 84 | 2007 |
| Identification of hemagglutinin structural domain and polymorphisms which may modulate swine H1N1 interactions with human receptor V Veljkovic, HL Niman, S Glisic, N Veljkovic, V Perovic, CP Muller BMC Structural Biology 9 (1), 62, 2009 | 82 | 2009 |
| Influenza vaccine as prevention for cardiovascular diseases: possible molecular mechanism V Veljkovic, S Glisic, N Veljkovic, T Bojic, U Dietrich, VR Perovic, ... Vaccine 32 (48), 6569-6575, 2014 | 81 | 2014 |
| Simple criterion for selection of flavonoid compounds with anti-HIV activity V Veljkovic, JF Mouscadet, N Veljkovic, S Glisic, Z Debyser Bioorganic & medicinal chemistry letters 17 (5), 1226-1232, 2007 | 63 | 2007 |
| Virtual screen for repurposing approved and experimental drugs for candidate inhibitors of EBOLA virus infection V Veljkovic, PM Loiseau, B Figadere, S Glisic, N Veljkovic, VR Perovic, ... F1000Research 4, 2015 | 56 | 2015 |
| Virtual screen for repurposing approved and experimental drugs for candidate inhibitors of EBOLA virus infection [v1; ref status V Veljkovic, PM Loiseau, B Figadere, S Glisic, N Veljkovic, VR Perovic, ... | 56* | 2015 |
| Virtual screen for repurposing approved and experimental drugs for candidate inhibitors of EBOLA virus infection [version 1; referees: 2 approved]. F1000Res. 2015; 4: 34 V Veljkovic, PM Loiseau, B Figadere PubMed Abstract| Publisher Full Text| Free Full Text, 0 | 56* | |
| Discovery of new therapeutic targets by the informational spectrum method N Veljkovic, S Glisic, J Prljic, V Perovic, M Botta, V Veljkovic Current Protein and Peptide Science 9 (5), 493-506, 2008 | 51 | 2008 |
| 14‐3‐3 Ligand Prevents Nuclear Import of c‐ABL Protein in Chronic Myeloid Leukemia M Mancini, N Veljkovic, V Corradi, E Zuffa, P Corrado, E Pagnotta, ... Traffic 10 (6), 637-647, 2009 | 44 | 2009 |
| Novel phylogenetic algorithm to monitor human tropism in Egyptian H5N1-HPAIV reveals evolution toward efficient human-to-human transmission VR Perovic, CP Muller, HL Niman, N Veljkovic, U Dietrich, DD Tosic, ... PLoS One 8 (4), e61572, 2013 | 42 | 2013 |
| The role of long-range intermolecular interactions in discovery of new drugs N Veljkovic, S Glisic, V Perovic, V Veljkovic Expert opinion on drug discovery 6 (12), 1263-1270, 2011 | 42 | 2011 |
| Novel virtual screening protocol based on the combined use of molecular modeling and electron-ion interaction potential techniques to design HIV-1 integrase inhibitors C Tintori, F Manetti, N Veljkovic, V Perovic, J Vercammen, S Hayes, ... Journal of chemical information and modeling 47 (4), 1536-1544, 2007 | 39 | 2007 |
| AIDS epidemic at the beginning of the third millennium: time for a new AIDS vaccine strategy V Veljkovic, R Metlas, H Köhler, HB Urnovitz, J Prljic, N Veljkovic, ... Vaccine 19 (15-16), 1855-1862, 2001 | 32 | 2001 |
| Natural products as promising therapeutics for treatment of influenza disease M Sencanski, D Radosevic, V Perovic, B Gemovic, M Stanojevic, ... Current pharmaceutical design 21 (38), 5573-5588, 2015 | 31 | 2015 |
| The association of V249I and T280M fractalkine receptor haplotypes with disease course of multiple sclerosis L Stojković, T Djurić, A Stanković, E Dinčić, O Stančić, N Veljković, ... Journal of neuroimmunology 245 (1-2), 87-92, 2012 | 30 | 2012 |
Vladimir PerovicComputer Scientist, Institute of Nuclear Sciences VINCA, University of Belgrade, Serba在 vinca.rs 的电子邮件经过验证
